Workshop-and telephone-based interventions to improve adverse drug reaction reporting: A cluster-randomized trial in Portugal

Drug Safety

Volumn 35, Issue 8, 2012, Pages 655-665

  Herdeiro, Maria Teresa ^a,b,c,d   Ribeiro Vaz, Ins ^a,b   Ferreira, Mnica ^d   Polnia, Jorge ^a   Falco, Amlcar ^e,f   Figueiras, Adolfo ^g,h  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c CESPU   (Portugal)

^d UNIVERSITY OF AVEIRO   (Portugal)

^e UNIVERSITY OF COIMBRA   (Portugal)

^f UNIVERSITY OF COIMBRA   (Portugal)

^g UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^h CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

HDKey words HDAdverse drug reaction reporting systems; Health education; Health surveillance; Intervention studies; Physicians

Indexed keywords

ADULT; CLINICAL PRACTICE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; FEMALE; FOLLOW UP; HUMAN; MALE; PHYSICIAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SPAIN; TELECONSULTATION; VOCATIONAL EDUCATION; WORKSHOP;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ATTITUDE OF HEALTH PERSONNEL; CLUSTER ANALYSIS; DRUG MONITORING; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHARMACOVIGILANCE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PORTUGAL; TELEPHONE;

EID: 84863826825     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11599750-000000000-00000     Document Type: Conference Paper

References (30)

1. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27 (7-8): 832-40 (Pubitemid 23225664)
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279 (15): 1200-5 (Pubitemid 28193431)
3. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329 (7456): 15-9 (Pubitemid 38869995)
4. Lasser KE, Allen PD, Woolhandler SJ, et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002; 287 (17): 2215-20 (Pubitemid 34441937)
5. Pedros C, Vallano A, Cereza G, et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf 2009; 32 (1): 77-83
6. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29 (5): 385-96
7. Herdeiro MT, Figueiras A, Polonia J, et al. Physicians' attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2005; 28 (9): 825-33 (Pubitemid 41428555)
8. Inman WHW. Assessment drug safety problems. In: Gent M, Shigmatsu I, editors. Epidemiological issues in reported drug-induced illnesses. Honolulu, Ontario: McMaster University Library Press, 1976: 17-24
9. Smith CC, Bennett PM, Pearce HM, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol 1996; 42 (4): 423-9 (Pubitemid 26340142)
10. Herdeiro MT, Figueiras A, Polonia J, et al. Influence of pharmacists' attitudes on adverse drug reaction reporting: a case-control study in Portugal.Drug Saf 2006; 29 (4): 331-40
11. Herdeiro MT, Polonia J, Gestal-Otero JJ, et al. Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional. J Eval Clin Pract 2004; 10 (4): 483-9 (Pubitemid 39469031)
12. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf 2009; 32 (1): 19-31
13. Figueiras A, Herdeiro MT, Polonia J, et al. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 2006; 296 (9): 1086-93 (Pubitemid 44348758)
14. World Health Organization, The Uppsala Monitoring Centre. Glossary of terms used in pharmacovigilance [online]. Available from URL: http://www.who-umc.org/graphics/25301.pdf [Accessed 2011 Feb 9]
15. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999; 319 (7211): 670-4 (Pubitemid 29423954)
16. Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS. 3rd ed. New York: Springer, 2006
17. Vorcewest TE, Barstow L, Butcher B. System for voluntary reporting of adverse drug-reactions in a university hospital. Am J Hosp Pharm 1989; 46 (11): 2300-3 (Pubitemid 19284591)
18. Sivaram C, Johnson S, Tirmizi SN, et al. Morning report: a forum for reporting adverse drug reactions. Jt Comm J Qual Improv 1996; 22 (4): 259-63
19. Castel JM, Figueras A, Pedros C, et al. Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads. Drug Saf 2003; 26 (14): 1049-55 (Pubitemid 37452645)
20. McGettigan P, Golden J, Conroy RM, et al. Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol 1997; 44: 98-100 (Pubitemid 27296803)
21. Backstrom M, Mjorndal T. A small economic inducement to stimulate increased reporting of adverse drug reactions: a way of dealing with an old problem? Eur J Clin Pharmacol 2006; 62: 381-5
22. Gilroy GW, Scollins MJ, Gay CA, et al. Pharmacycoordinated program that encourages physician reporting of adverse drug reactions. Am J Hosp Pharm 1990; 47: 1327-33 (Pubitemid 20185231)
23. Gony M, Badie K, Sommet A, et al. Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrenees region (Pharmaco-MIP) network 2-year pilot study. Drug Saf 2010; 33 (5): 409-16
24. Scott HD, Thacher-Renshaw A, Rosenbaum SE, et al. Physician reporting of adverse drug reactions: results of the Rhode Island adverse drug reaction reporting project. JAMA 1990; 263 (13): 1785-8 (Pubitemid 20113576)
25. Thomson O'Brien MA, Freemantle N, Oxman AD, et al. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2001: (2): CD003030
26. Davis D, O'Brien MA, Freemantle N, et al. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA 1999; 282 (9): 867-74 (Pubitemid 29408939)
27. Davis D, Thomson M, Oxman A, et al. Changing physicians performance: a systematic review of the effect of continuing medical education strategies. JAMA 1995; 274 (9): 700-5
28. Thomson O'Brien MA, Oxman AD, Davis DA, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000; (2): CD000409
29. Figueiras A, Sastre I, Tato F, et al. One-to-one versus group sessions to improve prescription in primary care: a pragmatic randomized controlled trial. Med Care 2001; 39 (2): 158-67 (Pubitemid 33603625)
30. Ribeiro-Vaz I, Herdeiro MT, Polonia J, et al. Strategies to increase the sensitivity of pharmacovigilance in Portugal. Rev Saude Publica 2010; 45 (1): 129-35